330 related articles for article (PubMed ID: 21577319)
21. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
Lee JH; Lee JH; Kim A; Kim I; Chae YS
Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
[TBL] [Abstract][Full Text] [Related]
22. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
23. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
[TBL] [Abstract][Full Text] [Related]
26. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of epithelial cell adhesion molecule in salivary gland neoplasms.
Phattarataratip E; Masorn M; Jarupoonphol W; Supatthanayut S; Saeoweiang P
Ann Diagn Pathol; 2016 Oct; 24():62-7. PubMed ID: 27649957
[TBL] [Abstract][Full Text] [Related]
28. Immuno-histochemical evaluation of Cathepsin D in malignant salivary gland carcinomas.
Sivaranjini Y; Angadi PV; Kumar GS
Gulf J Oncolog; 2012 Jan; (11):38-44. PubMed ID: 22227544
[TBL] [Abstract][Full Text] [Related]
29. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
Zhu F; Liu Z; Hou Y; He D; Ge X; Bai C; Jiang L; Li S
J Thorac Oncol; 2013 Dec; 8(12):1578-84. PubMed ID: 24389442
[TBL] [Abstract][Full Text] [Related]
30. Basal cell adenocarcinoma of the salivary gland: a morphological and immunohistochemical comparison with basal cell adenoma with and without capsular invasion.
Jung MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee SW; Cho KJ
Diagn Pathol; 2013 Oct; 8():171. PubMed ID: 24143938
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
32. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
33. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
[TBL] [Abstract][Full Text] [Related]
34. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
[TBL] [Abstract][Full Text] [Related]
35. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.
Zhang L; Mitani Y; Caulin C; Rao PH; Kies MS; Saintigny P; Zhang N; Weber RS; Lippman SM; El-Naggar AK
Am J Pathol; 2013 Jun; 182(6):2048-57. PubMed ID: 23583282
[TBL] [Abstract][Full Text] [Related]
36. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
37. Salivary gland-type cancers: cross-organ demographics of a rare cancer.
Tanzawa A; Saito K; Ota M; Takahashi K; Ohno I; Hanazawa T; Uzawa K; Takiguchi Y
Int J Clin Oncol; 2024 Jun; 29(6):755-763. PubMed ID: 38492066
[TBL] [Abstract][Full Text] [Related]
38. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma.
Clauditz TS; Gontarewicz A; Wang CJ; Münscher A; Laban S; Tsourlakis MC; Knecht R; Sauter G; Wilczak W
Diagn Mol Pathol; 2012 Sep; 21(3):134-7. PubMed ID: 22847156
[TBL] [Abstract][Full Text] [Related]
39. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
40. [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].
Kokemüller H; Brüggemann N; Brachvogel P; Eckardt A
Mund Kiefer Gesichtschir; 2004 May; 8(3):191-201. PubMed ID: 15138857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
